4 active not recruiting. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Active not recruiting 4 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Dermatitis, Atopic: new trials by email Literature Review of Dermatitis, Atopic trials Research Report on Dermatitis, Atopic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis Onabotulinum Toxin Type A - Phase 1b, Onabotulinum Toxin Type A - Phase 2 - Atopic Dermatitis (AD) | Phase 1 | Active not recruiting | Daniel Kaplan | 8 | 2025-07-17 | 2026-10-06 |
| An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis APG777, APG990, Dupilumab - Atopic Dermatitis | Phase 1 | Active not recruiting | Apogee Therapeutics, Inc. | 86 | 2025-06-04 | 2026-10-13 |
| Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult Participants GB-7624, Placebo - Atopic Dermatitis (AD) | Phase 1 | Active not recruiting | Generate Biomedicines | 40 | 2025-03-27 | 2025-12-05 |
| Evaluate the Safety, Tolerability of BAT6026 Monoclonal antibody BAT6026, sodium chloride injection - Dermatitis, Atopic | Phase 1 / Phase 2 | Active not recruiting | Bio-Thera Solutions | 33 | 2023-11-09 | 2026-10-02 |
Eczema (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Dermatitis (4) · Genetic Diseases, Inborn (4) · Hypersensitivity (4) · Hypersensitivity, Immediate (4) · Immune System Diseases (4) · Skin Diseases (4) · Skin Diseases, Eczematous (4) · Skin Diseases, Genetic (4) · Skin and Connective Tissue Diseases (4)
Sodium Chloride (1) · dupilumab (1)
Apogee Therapeutics, Inc. (1) · Bio-Thera Solutions (1) · Daniel Kaplan (1) · Generate Biomedicines (1)
Australia (2) · Canada (1) · China (1) · New Zealand (1) · United States (1)